Scios, Inc.

ACTIVE

加利福尼亚州圣克拉拉县, California, United StatesSubsidiary509 employeesEstablished: 1981-01-01

Part of 强生

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1981

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

36.4%

Phase 3

36.4%

Phase 1

4.5%

Phase 4

4.5%

Trial Status Distribution

Completed

90.9%

Terminated

4.5%

Withdrawn

4.5%

Clinical Trials

Trials sponsored by this organization (22)

A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure

Phase 3

Completed

interventional

May 20077,141 participants

Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC

Phase 2

Terminated

interventional

Sep 200616 participants

SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.

Phase 2

Completed

interventional

May 200562 participants

Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

Phase 2

Completed

interventional

Nov 200430 participants

A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure

Phase 2

Completed

interventional

Apr 2004920 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations

Scios, Inc.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (22)

A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure

Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC

SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.

Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

Registry for Acute Decompensated Heart Failure Patients Admitted to the ER

SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate

Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure

Approvals

News